[Preliminary observations on the clinical use of the glucosamide of N-p-chlorobenzoyl-2-methyl-5-methoxy-indol-3-acetic acid monohydrate].
D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D005260:Female; D006073:Gout / Q000188:drug therapy*; D006801:Humans; D007210:Indoleacetic Acids / Q000627:therapeutic use*; D007213:Indomethacin / Q000627:therapeutic use*; D007592:Joint Diseases / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D012216:Rheumatic Diseases / Q000188:drug therapy; D012585:Sciatica / Q000188:drug therapy
D000893:Anti-Inflammatory Agents; D007210:Indoleacetic Acids; D007213:Indomethacin
Osservazioni preliminari sull'impiego clinico della glucosamide dell'acido N-p-chlorobenzoil-2-metil-5-metoxxi-indol-3-acetico monoidrato